Year: 2022 | Month: June | Volume 9 | Issue 1

Pulmonary Complications among Discharged COVID-19 Patients – A Prospective Study

Suhail Neliyathodi Akshaya Kumar


Background: There is a need for a unified pathway and structure for the respiratory follow-up of patients with COVID-19 pneumonia. Introduction: The long-term complications of COVID-19 pneumonia-pulmonary fibrosis, pulmonary vascular disease, bronchial hyper-reactivity, and pleural effusion are real and need evaluation. Methodology: A  prospective study was conducted in November 2020–January 2021 among the patients discharged from MES COVID hospital. Aim: The aims of this study were to estimate the prevalence of pulmonary complications among discharged COVID-19  patients and to study the risk factors and long-term outcome of pulmonary fibrosis in COVID. Results: Out of the 300  patients studied, most common outcome was pulmonary fibrosis – 10.7%; followed by death (9%), pleural effusion (2%), bronchial hyper-reactivity (1.3%), pulmonary embolism (0.3%), anosmia (0.3%), pneumothorax (0.3%), and organizing pneumonia (0.3%). Conclusion: Most of the complications were seen among Cat-C patients, the most common being pulmonary fibrosis which showed a serial decrement in the chest X-ray scores suggesting favorable outcome.

© This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited


post COVID
pulmonary fibrosis

Print This Article Email This Article to Your Friend

International Journal of Dental and Medical Specialty | In Association with SMOD. 37704033 - Visitors since June 1, 2015